Pfizer drops 2% as sellers retake control
Pfizer drops 2% as sellers retake control after last week's bounce
Pfizer drops 2% as sellers retake control
Our view last week
Pfizer confirms its double bottom in the 24 area for a third straight week, and this time the bounce has teeth: up 3.6%, with the weekly RSI climbing to 45. The bigger tell comes from money flow, which after weeks in the red has crossed back above zero and turned positive — sellers are giving ground to buyers. The Sell signal, under management for 11 weeks now, stays only marginally in profit for the short.
This week's summary
Pfizer dropped 2% this week, with 96% of trading volume on the sell side: buyers pulled back after last week's bounce. In our Pfizer technical analysis, the Sell signal has been under management for 11 weeks, and the short remains only marginally in profit. The stock still holds the double bottom in the 24 area, with money flow staying positive: a contested picture, with the trend losing conviction.
IQS Phase
85
in tension / maturity
Signal Strength
31
decline starting to make lower lows
Sizing
REDUCED
Ranking
#89 / 141
US stocks
Trade P&L %
+4.44%
from signal to today
Rank position
ranks 89th among the 141 sell signals for US stocks in our ranking, with a signal strength of 31 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
PFE belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content